Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients

BACKGROUND: Several reports suggest that vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma (mRCC) may be more toxic in Asian vs non-Asian populations. Comparative efficacy of these agents with respect to ethnicity is not well characterised. METHODS: A mult...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Y, Choueiri, T K, Lee, J-L, Tan, M-H, Rha, S Y, North, S A, Kollmannsberger, C K, McDermott, D F, Heng, D Y C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3960609/
https://ncbi.nlm.nih.gov/pubmed/24548864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados